By definition, UC is inflammation limited to the large intestinal portion of the digestive tract. However, there are a variety of extra intestinal manifestations (EIMs) documented.
How can UC affect the heart? It's mostly in broadly vague ways that are a little hard to pin down through tests. There also might be some misunderstanding with this cardiologist in what UC can/cannot due (like UC causing Esophagus or stomach inflammation which it cannot). UC causes inflammation of the large intestine and inflammation elsewhere in the body is possible as an EIM (joint pains are joint inflammation, sinus inflammation, eye inflammation uveitis, etc etc). It is collateral damage from an immune attack targeted at the intestine, but the White Blood Cells, and other immune cells are circulating body wide during their journey. Immune cells are certainly on high-alert
and might attack elsewhere. We tend to clot easier as UC patients, and are more prone to big vein clots like DVT or Pulmonary Embolism. Our blood work can be abnormal in expected and unexpected ways (some of which explain the likelihood of clotting, and other things of that nature). Certain medications, like mesalamine/5-ASA can cause heart inflammation in rare incidents (such as your Apriso) causing medication-induced Myocarditis/Pericarditis which is listed on that medication's informational insert. Beyond that, I am not sure what this cardiologist is referring to.
So, certainly as far as inflammation or clotting within the heart go, having UC or the medications you take for UC might have low odds of complications to your heart. There are of course other explanations to your heart symptoms, and those should likely be explored as well.
Certainly that is an interesting point, and I'd encourage you to report back on what your gasteroenteroligist shares about
this when next you meet him/her.
Did some searchng on http://scholar.google.com/ for UC and heart complications.
Chronic inflammatory bowel disease and cardiovascular complications - 2006Abstract
The most common extraintestinal manifestations of Crohn's disease and ulcerative colitis are iritis and uveitis, primary sclerosing cholangitis (PSC) and nodal erythema and pyoderma gangrenosum. Complications within the cardiovascular system seem to be uncommon, but there are no systematic investigations concerning the epidemiology of these manifestations. There are more than 100 cases reported about
pericarditis and perimyocarditis in patients with inflammatory bowel disease. Other patients with Crohn's disease or ulcerative colitis suffer from vasculitis, representing a further mechanism of inflammatory diseases of the cardiovascular system. There are several case reports showing a combination of Takayasu's arteritis and Crohn's disease, and cross-reacting antibodies against gut mucosa and aortic tissue were found. Some patients developed thrombotic complications by activating the coagulation system, which can result in atrial thrombi, embolism of the pulmonary arteries, myocardial infarction and disseminated intravascular coagulopathy (DIC). Furthermore, a few case were reported about
atrio ventricular blocks, amyloidosis of the heart, dilative cardiomyopathy and endomyocardial fibrosis in patients with chronic inflammatory bowel disease. Here, a 27-year-old patient with known ulcerative colitis for 2 years is reported, who presented in the authors' department with unstable angina pectoris. Coronary angiographic examination was immediately performed and diffuse intracoronary thrombi were found, which could be removed by the catheter procedure. A myocardial infarction did not develop. Because of positive anti neutrophil cytoplasmic antibodies (p-ANCA) a p-ANCA-positive arteritis of the coronary vessels with intracoronary thromboembolism due to ulcerative colitis was diagnosed. Systematic studies or investigations concerning the epidemiology of the cardiovascular complications are still lacking, so that an overview about
the published data is given.
(unfortunately the rest pf the article is behind a payment gateway)
Source:
https://europepmc.org/abstract/med/16802521